pml targeting eradicates quiescent leukaemia-initiating cells
existence small population cancer-initiating cells responsible tumour maintenance firmly demonstrated leukaemia concept currently tested solid tumours leukaemia-initiating cells particularly quiescent state thought resistant chemotherapy targeted therapies resulting disease relapse chronic myeloid leukaemia paradigmatic haematopoietic stem cell disease leukaemia-initiating-cell pool eradicated current therapy leading disease relapse drug discontinuation define critical role promyelocytic leukaemia protein pml tumour suppressor haematopoietic stem cell maintenance present new therapeutic approach targeting quiescent leukaemia-initiating cells possibly cancer-initiating cells pharmacological inhibition pml
